Pre-approved antiviral drugs could be first line of defense for COVID-19 infection

Pre-approved antiviral drugs could be first line of defense for COVID-19 infection

Pre-approved antiviral drugs could be first line of defense for COVID-19 infection
Pre-approved antiviral drugs could be first line of defense for COVID-19 infection